Business● Low2h ago · Nov 6, 2026, 4:15 AM
Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Ginkgo has reaffirmed its cash burn guidance for 2026 at $125 million-$150 million and announced its first sale of an autonomous lab to Novo Nordisk. This indicates the company's financial projections and a new business venture in the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business7m agoGlobal stock rout deepens as AI data centre fears fuel worst US chip sell-off since 2020EuroNews [en]Business13m agoMicrochip expects December-quarter revenue down 3% to up 1% while targeting $0.87-$0.95 non-GAAP EPSSeeking Alpha TechBusiness14m agoDiversified Energy anticipates ~$440M 2026 adjusted free cash flow while Birch deal targets ~$455M of next-12-month free cash flowSeeking Alpha TechBusiness16m agoThermo Fisher Scientific announces $5B share repurchase authorizationSeeking Alpha Tech